Congress 108 - HR 2544 - Medical Independence, Privacy, and Innovation Act of 2003

Sponsor

Cosponsors

Topics

Administrative procedure Administrative remedies Bank accounts Civil Rights and Liberties, Minority Issues Clinical trials Coinsurance Commerce Crime and Law Enforcement Criminal justice information Department of Health and Human Services Drug approvals Drug industry Drug interactions Drugs Excise tax Executive reorganization Finance and Financial Sector Foreign Trade and International Finance Government Operations and Politics Government paperwork Government property Government publicity Governmental investigations Health Health insurance Imports Income tax Insurance premiums Intellectual property Inventions Labeling Law Licenses Marketing Medical economics Medical records Medical savings accounts Minorities Minority health Ombudsman Packaging Patent infringement Patents Patient satisfaction Patients' rights Pharmaceutical research Pharmacies Right of privacy Science, Technology, Communications Tax credits Tax deductions Tax exclusion Tax exemption Tax penalties Taxation Trusts and trustees Wholesale trade Women Women's health

Full Text

View Full Bill Text

Votes

Summary

Medical Independence, Privacy, and Innovation Act of 2003 - Amends the Internal Revenue Code to eliminate language making the medical expense deduction only apply to the extent the relevant expenses exceed 7.5 percent of adjusted gross income. Permits the deduction in computing adjusted gross income.

Exempts medical checking accounts from being subjected to certain taxes. Subjects such accounts to taxes on unrelated business income of charitable organizations. Allows a deduction equal to the amount paid in cash to an individual's medical checking account (up to $1,000, or $2,000 in the case of a joint return) and a credit (of up to $1,000) for contributions made to such account.

Excludes from gross income any amount paid or distributed out of a medical checking account which is used exclusively to pay qualified medical expenses of any account holder.

Decreases the minimum annual deductibles under a high deductible health plan for purposes of Archer medical savings accounts.

Makes modifications to regulations regarding the privacy of individually identifiable health information.

Prohibits the granting of an exclusive or partially exclusive license regarding an invention made with Federal assistance, except in accordance with specified provisions of Federal law pertaining to the licensing of Federally owned inventions.

Amends the Federal Food, Drug, and Cosmetic Act to direct the Secretary to promulgate regulations permitting pharmacists and wholesalers to import prescription drugs from foreign nations, with such regulations to require that each such drug complies with sections of the Act pertaining to new drugs, adulterated drugs and devices, and misbranded drugs and devices, and with other applicable requirements of this Act. (Current law directs the Secretary to promulgate regulations permitting pharmacists and wholesalers to import prescription drugs, except for specified controlled substances and biological products).

Actions

Sep 4, 2003

Referred to the Subcommittee on Courts, the Internet, and Intellectual Property.
Jul 1, 2003

Referred to the Subcommittee on Health.
Jun 27, 2003

Referred to the Subcommittee on Health.
Jun 24, 2003

Sponsor introductory remarks on measure. (CR H5808-5811)
Jun 19, 2003

Referred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 19, 2003

Introduced in House

Amendments

Related Bills